₹23.00
as total savings
(including Shipping)
₹23
will be deposited into your Dermawallet as cashback after delivery
Tranexamic Acid
Tranexamic Acid (TXA) for Melasma, Stubborn Pigmentation, and Redness: Complete Ingredient Guide
Tranexamic Acid (TXA) is a synthetic derivative of the amino acid lysine. While originally developed as an oral medication to prevent excessive bleeding, dermatologists discovered its profound ability to treat melasma and hyperpigmentation when applied topically. Unlike conventional brightening ingredients that target the tyrosinase enzyme directly, Tranexamic Acid works upstream by blocking the biochemical signals that ultraviolet (UV) radiation and inflammation send to melanocytes.
At a Glance: Tranexamic Acid
| Attribute | Detail |
|---|---|
| INCI Name | Tranexamic Acid |
| Alternate Names | TXA, trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid |
| Category | Clinical Active — Pigment Inhibitor and Anti-Inflammatory |
| Primary Functions | Upstream melanin signal blockade, inflammatory cytokine suppression, vascular redness reduction |
| Studied Concentration | 2% to 5% (Topical cosmetic formulations) |
| pH Requirement | Highly stable across a broad pH range (typically 5.0 to 7.0) |
| Photosensitizing Risk | None; safe for daytime use without increasing UV sensitivity |
| Regulatory Status | Globally recognized as safe and effective for topical cosmetic use; originally an oral antifibrinolytic medication |
What Is Tranexamic Acid and Why Does It Work?
Unlike conventional brightening ingredients (like Kojic Acid or Alpha Arbutin) that target the tyrosinase enzyme directly, Tranexamic Acid works upstream. It blocks the biochemical signals that ultraviolet (UV) radiation and inflammation send to melanocytes (pigment-producing cells).
By interrupting this communication pathway, TXA prevents melanin overproduction at the source, making it highly effective for treatment-resistant pigmentation with an exceptionally low risk of irritation.
Functional Role in Skincare
| Functional Role | Category | Sub-role Mechanism |
|---|---|---|
| Primary Active | Upstream Signal Blockade | Inhibits the plasminogen/plasmin pathway in keratinocytes, preventing them from signaling melanocytes to overproduce melanin in response to UV or inflammation. |
| Primary Active | Anti-Inflammatory | Suppresses the release of arachidonic acid and prostaglandins, reducing the localized inflammation that triggers post-inflammatory hyperpigmentation (PIH). |
| Supporting Active | Vascular Redness Reduction | Minimizes the density of superficial blood vessels, addressing the erythema (redness) often associated with melasma and active breakouts. |
Skin Concerns Tranexamic Acid Treats
| Skin Concern | Root Cause Addressed | Mechanism of Action | Studied Concentration | Research Anchor |
|---|---|---|---|---|
| Melasma | Hormonal fluctuations combined with UV exposure driving persistent melanocyte activation. | Blocks the upstream keratinocyte-melanocyte signaling pathway, addressing the root cause where direct tyrosinase inhibitors often fall short. | 2% to 5% | J Cosmet Dermatol, 2020 (PMID 31737977) |
| Stubborn Post-Inflammatory Hyperpigmentation (PIH) | Persistent melanin overproduction following severe or recurring acne breakouts. | Interrupts the inflammatory cascade that sustains pigment production, fading marks that have not responded to conventional brighteners. | 2% to 5% | Dermatol Surg, 2014 (PMID 24579599) |
| Persistent Skin Redness and Reactivity | Chronic low-grade inflammation from environmental stressors or compromised barriers. | Reduces inflammatory cytokine activity, calming background reactivity and visible erythema. | 2% to 5% | J Cosmet Dermatol, 2020 (PMID 31737977) |
Why Tranexamic Acid Is Effective for Indian Skin and Climate
Melasma affects an estimated 25% to 30% of Indian women, a prevalence significantly higher than global averages. This is driven by India’s intense, year-round UV exposure combined with genetic predisposition and hormonal factors.
Addressing the Upstream Trigger: Conventional brightening actives target tyrosinase directly. However, in melasma-prone Indian skin, the upstream signaling from keratinocytes to melanocytes remains hyperactive. Tranexamic Acid interrupts this specific signaling layer, making it a more clinically appropriate choice for the Indian demographic.
Humidity-Driven Stubborn PIH: Breakouts triggered by sweat and humidity often leave persistent marks on Fitzpatrick Skin Types IV to VI. When these marks do not fade adequately with standard actives, TXA addresses the lingering inflammatory signaling that keeps the pigment active.
Gentle Efficacy: Indian skin is frequently stressed by hard water, pollution, and harsh sun. TXA provides potent pigmentation correction without the irritation, peeling, or barrier disruption associated with strong acids, making it safe for long-term daily use.
How Tranexamic Acid Works: Three Mechanisms of Action
1. Plasminogen Pathway Inhibition (Upstream Blockade)
UV exposure and inflammation cause skin cells (keratinocytes) to release plasmin. Plasmin triggers the release of arachidonic acid, which signals melanocytes to produce melanin. Tranexamic Acid binds to plasminogen receptors, blocking this entire cascade before tyrosinase is even activated.
2. Anti-Inflammatory Modulation
TXA competitively inhibits the binding of plasminogen to keratinocytes, which subsequently reduces the production of prostaglandins and inflammatory cytokines. This calms the skin and prevents inflammation from triggering new pigment formation.
3. Vascular Component Reduction
Melasma and severe PIH often have a vascular component (visible redness or broken capillaries beneath the pigment). Tranexamic Acid helps normalize these superficial blood vessels, reducing the underlying redness that makes pigmentation appear more prominent.
Clinical Evidence: Peer-Reviewed Research
| Concentration | Outcome Measured | Study Type | Source & Year | Key Finding |
|---|---|---|---|---|
| 3% to 5% | Melasma severity (MASI score) reduction | Randomized Controlled Trial | J Cosmet Dermatol, 2020 | Topical TXA demonstrated significant improvement in melasma compared to vehicle control over 12 weeks, showing efficacy comparable to 2% hydroquinone. (PMID 31737977) |
| 2% to 5% | Melasma reduction and tolerability | Clinical Study | Dermatol Surg, 2014 | Topical TXA significantly reduced the Melasma Area and Severity Index (MASI) score and was exceptionally well-tolerated in an Asian patient population. (PMID 24579599) |
| Various | Post-inflammatory hyperpigmentation | Clinical Evaluation | J Drugs Dermatol, 2016 | TXA effectively reduced the intensity and duration of PIH by interrupting the inflammatory signaling cascade post-acne. |
Who Should Use Tranexamic Acid: Skin Type Guide
| Primary Concern | Skin Type | Severity | Recommended Approach |
|---|---|---|---|
| Melasma and hormonal pigmentation | All skin types | Moderate to severe | Apply a 2% to 5% TXA serum daily, paired strictly with broad-spectrum SPF. |
| Stubborn post-acne dark marks | Oily, acne-prone | Moderate | Use a TXA serum combined with Niacinamide or Azelaic Acid to target both the mark and the underlying inflammation. |
| Sensitive or rosacea-prone skin | Sensitive, reactive | Mild to moderate | TXA is one of the best-tolerated brightening actives. It can be used daily from day one without a build-up period. |
| General dullness and uneven tone | Normal, dry | Mild | Use as a preventive measure against UV-induced signaling and to maintain an even complexion. |
How to Use Tranexamic Acid: Application Guide
Beginner to Advanced Routine
Beginner
New to brightening actives
1
Apply a 2% to 5% Tranexamic Acid serum once or twice daily.
2
No adjustment or build-up period is needed due to its gentle profile.
Intermediate
Established routine
1
Layer TXA under your moisturizer morning and evening.
2
It is highly stable and safe to combine with other brightening actives like Vitamin C or Niacinamide.
Advanced
Targeted correction
1
Use a dedicated TXA serum alongside a gentle chemical exfoliant (like Mandelic or Lactic Acid).
2
Apply on alternate nights to accelerate the shedding of existing pigmented cells while TXA stops new pigment signaling.
Application Rules
AM/PM Suitability: Safe and effective for both morning and evening routines.
Routine Step: Apply after water-based cleansing and toning, but before heavier moisturizers or oils.
Sunscreen Requirement: Daily SPF 30+ is non-negotiable. While TXA does not cause photosensitivity, unprotected UV exposure will continuously re-activate the plasminogen signaling pathway, reversing the ingredient's benefits.
Patch Testing: Apply a small amount behind the ear or on the inner forearm. Wait 24 hours. The risk of reaction is very low, but patch testing is always recommended when introducing any new active.
What Tranexamic Acid Cannot Do
Does not exfoliate the skin: It is a signaling inhibitor, not a keratolytic. It stops new melanin production but does not physically remove existing pigmented dead skin cells.
Does not work instantly: Pigment correction requires waiting for the skin's natural cellular turnover cycle. Visible results take 8 to 12 weeks of consistent daily use.
Does not replace sunscreen: Without strict UV protection, sunlight will continuously trigger the upstream signaling pathway, rendering Tranexamic Acid's inhibitory effects ineffective.
Does not cure deep dermal melasma alone: While highly effective for epidermal pigmentation, deep, hormone-driven dermal melasma often requires a multi-ingredient approach (e.g., combining with oral medications or chemical peels) under dermatological guidance.
Tranexamic Acid Compatibility: Pairing Guide
| Ingredient | Compatibility | Mechanism Relationship | Benefit of Pairing |
|---|---|---|---|
| Kojic Acid / Alpha Arbutin | Highly Recommended | Multi-pathway brightening | TXA blocks the upstream signal, while Kojic Acid and Arbutin inhibit the tyrosinase enzyme downstream, providing comprehensive pigment control. |
| Niacinamide | Highly Recommended | Complementary mechanisms | Niacinamide blocks melanin transfer to the skin surface, while TXA blocks melanin production at the signaling stage. |
| Azelaic Acid | Highly Recommended | Synergistic anti-inflammatory | Azelaic Acid provides additional anti-inflammatory support and mild antibacterial action alongside TXA's upstream blockade. |
| Vitamin C | Recommended | Antioxidant synergy | Vitamin C neutralizes free radicals that trigger inflammation, while TXA blocks the resulting pigment signaling. |
How to Find the Right Tranexamic Acid for You (The Derma Co Range)
The Derma Co formulates Tranexamic Acid into targeted solutions to address stubborn pigmentation and inflammation across all skin types:
For Melasma or Deep PIH: Tran-Zelaic Pigmentation Corrector Serum (30ml) – Combines Tranexamic Acid with Azelaic Acid for comprehensive upstream signaling blockade and anti-inflammatory action.
For Acne-Related PIH + Redness: 10% Cica-Glow Face Serum (30ml) – Blends Tranexamic Acid with soothing Cica (Centella Asiatica) to fade marks while calming active inflammation.
For Brightening + Barrier Support: 5% Cica-Glow Daily Face Moisturizer (50g) – Delivers gentle, daily TXA benefits alongside deep hydration and barrier repair.
For Gentle Daily Cleansing: Tran-Zelaic Pigmentation Corrector Face Wash (80ml) and 2% Cica-Glow Daily Face Wash (100ml) – Provide mild, wash-off pigment correction without stripping the skin.
Note: The Derma Co’s Tranexamic Acid range is mid-range and budget-accessible, with serums and moisturizers priced from approximately ₹599 to ₹799, and face washes from ₹399 to ₹599.
Frequently Asked Questions About Tranexamic Acid
Q: How does Tranexamic Acid fade dark spots differently than other ingredients?
A: Unlike ingredients that target the tyrosinase enzyme directly, Tranexamic Acid works upstream. It blocks the plasminogen signaling pathway, preventing skin cells from telling melanocytes to overproduce melanin in response to UV light or inflammation.
Q: Is Tranexamic Acid safe for sensitive skin?
A: Yes. It is one of the best-tolerated brightening actives available. It does not cause exfoliation, peeling, or barrier disruption, making it highly suitable for sensitive, reactive, and rosacea-prone skin.
Q: Can Tranexamic Acid be used with Niacinamide and Vitamin C?
A: Yes. Tranexamic Acid is highly stable and pairs excellently with Niacinamide and Vitamin C. Together, they create a multi-pathway approach to brightening without increasing the risk of irritation.
Q: How long does Tranexamic Acid take to show results?
A: Visible improvement in post-inflammatory hyperpigmentation and overall skin tone typically takes 8 to 12 weeks of consistent daily use. Significant reduction in melasma may require 12 to 16 weeks alongside strict sunscreen use.
Q: Do I need to wear sunscreen if I use Tranexamic Acid?
A: Yes, daily application of SPF 30 or higher is mandatory. Tranexamic Acid blocks the skin's response to UV damage, but it does not block the UV rays themselves. Sunscreen is required to prevent the signaling pathway from being re-activated.
References
- J Cosmet Dermatol. 2020. Topical tranexamic acid demonstrated significant improvement in melasma compared to vehicle control over 12 weeks, showing efficacy comparable to 2% hydroquinone. (PMID 31737977)
- Dermatol Surg. 2014. Topical tranexamic acid significantly reduced the Melasma Area and Severity Index (MASI) score and was exceptionally well-tolerated in an Asian patient population. (PMID 24579599)
- J Drugs Dermatol. 2016. Tranexamic acid effectively reduced the intensity and duration of post-inflammatory hyperpigmentation by interrupting the inflammatory signaling cascade.
- Ebrahimi, B., & Naeini, F. F. Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci. 2014;19(8):753-757.
- Lee, J. H., et al. Efficacy and safety of topical tranexamic acid in the treatment of melasma: A systematic review and meta-analysis. J Am Acad Dermatol. 2018.